Disclosures for "Long-term Safety and Effectiveness of ZYN002 Cannabidiol Transdermal Gel in the Treatment of Irritability-Related Behavioral Symptoms in Children and Adolescents with Fragile X Syndrome: Update to Open-Label Extension Study (ZYN2-CL-017)"
-
Dr. Bzdek has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Bzdek has stock in Harmony Biosciences.
-
Mr. Thibodeau has received personal compensation for serving as an employee of Harmony Biosciences.
-
Dr. Tich has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Tich has stock in Harmony Biosciences.
-
Dr. Albers has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Albers has stock in Harmony Biosciences.
-
Dr. Nomikos has received personal compensation for serving as an employee of Harmony Biosciences.